Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Zhang T, Qu R, Chan S, Lai M, Tong L, Feng F, Chen H, Song T, Song P, Bai G, Liu Y, Wang Y, Li Y, Su Y, Shen Y, Sun Y, Chen Y, Geng M, Ding K, Ding J, Xie H.
Zhang T, et al. Among authors: chan s.
Mol Cancer. 2020 May 13;19(1):90. doi: 10.1186/s12943-020-01202-9.
Mol Cancer. 2020.
PMID: 32404161
Free PMC article.